A young man with unusual blood clots in the spleen was ultimately diagnosed with immune-mediated thrombotic thrombocytopenic purpura (TTP) — also known as acquired…
News
Oral hetrombopag safely boosts platelet counts and reduces bleeding and the need for rescue therapy in adults with persistent immune thrombocytopenia (ITP) who have…
The rare coexistence of von Willebrand disease (VWD) type 3 and factor V Leiden (FVL) can put patients at risk for…
The number of cases of the blood disorder thrombotic thrombocytopenic purpura (TTP) did not increase during the pandemic, but COVID-19 was linked to more…
People with immune thrombocytopenia (ITP) are at high risk of developing blood clots that block circulation, according to an analysis that combined results of…
Heavy menstrual bleeding (HMB) affects 93% of women with von Willebrand disease (VWD) at some point in life, according to a Swedish study that…
Pregnant women with thrombotic thrombocytopenic purpura (TTP) in the U.S. are nearly 20 times more likely to experience an adverse maternal outcome, according to…
An arm of the European Medicines Agency (EMA) is recommending that Wayrilz (rilzabrutinib) be approved to treat adults with immune thrombocytopenia (ITP) who…
Researchers created an experimental treatment for von Willebrand disease (VWD) type 1 that aims to stabilize the protein whose defect causes the disease, increasing…
Switching from treatment with fresh frozen plasma (FFP) to Adzynma (ADAMTS13, recombinant-krhn) can help people with congenital thrombotic thrombocytopenic purpura (TTP) avoid hospital stays,…
